Related Experiment Video
Updated: Jul 19, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Serum eosinophil cationic protein in children with atopic dermatitis
S Murat-Susić1, J Lipozencić, V Zizić
1Department of Dermatovenerology, Zagreb University Hospital Center, Children's Hospital, Zagreb, Croatia. slosusic@vef.hr
Insights
Children with atopic dermatitis (AD) show elevated eosinophil cationic protein (ECP), eosinophil counts, and IgE antibodies. However, these markers do not correlate with AD severity, suggesting their use as supplementary evaluation tools.
Area of Science:
- Pediatric Allergy and Immunology
- Dermatology
- Clinical Laboratory Science
Background:
- Eosinophil cationic protein (ECP) is a key mediator released by eosinophils during allergic inflammation.
- Atopic dermatitis (AD) is a common inflammatory skin condition characterized by elevated eosinophil activity.
- Understanding biomarkers associated with AD severity is crucial for effective patient management.
Purpose of the Study:
- To compare ECP levels, eosinophil counts, and IgE antibodies in children with AD versus non-atopic children.
- To investigate the correlation between these laboratory parameters and the clinical severity of AD, as measured by the SCORAD index.
Main Methods:
- A prospective study involving 70 children (49 with AD, 21 controls).
- Measurements included serum ECP, absolute and relative eosinophil counts, and total serum IgE.
- Clinical severity of AD was assessed using the SCORAD index.
Main Results:
- Children with AD exhibited significantly higher median levels of IgE antibodies, and absolute and relative eosinophil counts compared to controls (P < 0.001).
- Serum ECP levels were also significantly higher in children with AD (median 16.2 microg/L) than in controls (median 5.92 microg/L).
- No statistically significant correlation was found between ECP levels and the SCORAD index or its components (intensity, extent, subjective symptoms).
Conclusions:
- Elevated ECP, eosinophil counts, and IgE antibodies are characteristic of AD in children.
- These laboratory findings did not correlate with the clinical severity of AD.
- ECP, eosinophil counts, and IgE may serve as additional, but not primary, evaluation methods for AD patients.
Background:
Eosinophil cationic protein (ECP) is a cytotoxic agent secreted by activated eosinophils during allergic and inflammatory processes. The aim of the study was to determine the ECP level, absolute and relative eosinophil count and IgE antibodies in children with atopic dermatitis (AD) compared with those of nonatopic children, and to assess the correlation of these laboratory parameters with the clinical severity of AD.
Methods:
This prospective study comprised 70 children. There were 49 children with AD aged 3-36 months, and the control group comprised 21 children with a negative personal and family history for atopic diseases. Detailed history, serum ECP levels (UniCAP FEIA), relative and absolute eosinophil counts and total serum IgE antibodies were determined in both groups. In the children with AD, skin involvement was measured by the SCORAD index.
Results:
The calculated SCORAD index was between 16 and 83. IgE antibodies, relative and absolute eosinophil counts showed a significantly wider range of values and a statistically higher median (P < 0.001) in the patients with AD compared with the control group. These laboratory parameters did not correlate with the severity of AD. The serum ECP median level, in the children with AD, was 16.2 microg/L (range 3.01-65.30) compared with 5.92 microg/L (range 2.76-21.90) in the control group. Correlation of the total SCORAD index and the serum ECP levels was negative, weak (r = -0.065) and statistically not significant (P > 0.05). The same was found for the correlation of serum ECP and intensity of skin changes (r = -0.095) and serum ECP and subjective symptoms (r = -0.045). The correlation was positive, but weak and statistically not significant for the serum ECP and extent of the skin lesions (r = 0.079, P > 0.05).
Conclusion:
Elevated levels of ECP, relative and absolute eosinophil counts, as well as IgE antibodies were determined in the patients with AD. As these laboratory findings did not correlate with the severity of AD, they can be considered only as additional methods in the evaluation of patients with AD.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma I: Introduction
Clinical Applications of Epidermal Stem Cells

